LINCOCINE SOLUTION
LINCOCINE SOLUTION
Authorised
- Lincomycin hydrochloride monohydrate
Product identification
Medicine name:
LINCOCINE SOLUTION
Active substance:
- Lincomycin hydrochloride monohydrate
Target species:
-
Dog
-
Pig
-
Cat
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Lincomycin hydrochloride monohydrate113.39/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Dog
-
Pig
-
Meat and offal7day
-
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
- Bela-Pharm GmbH & Co. KG
- Zoetis Belgium
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/8003002 1/1988
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 7/02/2025
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 11/12/2024
How useful was this page?:
